Artificial Intelligence-Based Quality Control of Cell Lines.

IF 1.4 4区 生物学
Svetlana Gramatiuk, Igor A Kryvoruchko, Yulia V Ivanova, Emily Hubbard, Maria Noebauer-Babenko, Karine Sargsyan
{"title":"Artificial Intelligence-Based Quality Control of Cell Lines.","authors":"Svetlana Gramatiuk, Igor A Kryvoruchko, Yulia V Ivanova, Emily Hubbard, Maria Noebauer-Babenko, Karine Sargsyan","doi":"10.1177/19475535251367317","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Introduction:</i></b> This study is part of the broader Stem Line project Mito-Cell-UAB073, specifically focusing on \"Stem Cell Lines-Quality Control,\" and aims to innovate in the field of Quality Control (QC) through a unique, artificial intelligence (AI)-powered model known as Life Cell AI UAB. This model utilizes deep learning algorithms and computer vision, allowing it to make accurate viability assessments of cell and stem cell lines based solely on static images captured through standard optical microscopes. <b><i>Aim:</i></b> The aim of this study was to develop and validate an AI-driven, image-based model that reliably predicts cell line viability. <b><i>Methods:</i></b> Our methodology involved training the Life Cell AI UAB model on single static images of cell lines using advanced computer vision and deep learning techniques. Performance evaluation was conducted on three independent blind test sets sourced from various biotechnology laboratories, allowing for assessment across diverse environments. <b><i>Results:</i></b> The Life Cell AI UAB model achieved a sensitivity of 82.1% in identifying viable cell lines and a specificity of 67.5% for non-viable lines across the test sets. Each blind test set exhibited a weighted accuracy above 63%, with a combined accuracy of 64.3%. Notably, predictions showed a clear distinction between correctly and incorrectly classified cells. The model outperformed traditional QC methods by improving accuracy in binary classification tasks by 21.9% (<i>p</i> = 0.042) and demonstrated a 42.0% enhancement over conventional Standard Operation Procedure (SOP) procedures (<i>p</i> = 0.026). <b><i>Conclusion:</i></b> The Life Cell AI UAB model represents a notable advancement in biobanking QC, offering a precise, standardized, and non-invasive method for assessing cell line viability. This model has the potential to streamline QC processes across laboratories, minimizing the need for time-lapse imaging and promoting uniformity in QC practices for both cell and stem cells.</p>","PeriodicalId":55358,"journal":{"name":"Biopreservation and Biobanking","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopreservation and Biobanking","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1177/19475535251367317","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study is part of the broader Stem Line project Mito-Cell-UAB073, specifically focusing on "Stem Cell Lines-Quality Control," and aims to innovate in the field of Quality Control (QC) through a unique, artificial intelligence (AI)-powered model known as Life Cell AI UAB. This model utilizes deep learning algorithms and computer vision, allowing it to make accurate viability assessments of cell and stem cell lines based solely on static images captured through standard optical microscopes. Aim: The aim of this study was to develop and validate an AI-driven, image-based model that reliably predicts cell line viability. Methods: Our methodology involved training the Life Cell AI UAB model on single static images of cell lines using advanced computer vision and deep learning techniques. Performance evaluation was conducted on three independent blind test sets sourced from various biotechnology laboratories, allowing for assessment across diverse environments. Results: The Life Cell AI UAB model achieved a sensitivity of 82.1% in identifying viable cell lines and a specificity of 67.5% for non-viable lines across the test sets. Each blind test set exhibited a weighted accuracy above 63%, with a combined accuracy of 64.3%. Notably, predictions showed a clear distinction between correctly and incorrectly classified cells. The model outperformed traditional QC methods by improving accuracy in binary classification tasks by 21.9% (p = 0.042) and demonstrated a 42.0% enhancement over conventional Standard Operation Procedure (SOP) procedures (p = 0.026). Conclusion: The Life Cell AI UAB model represents a notable advancement in biobanking QC, offering a precise, standardized, and non-invasive method for assessing cell line viability. This model has the potential to streamline QC processes across laboratories, minimizing the need for time-lapse imaging and promoting uniformity in QC practices for both cell and stem cells.

基于人工智能的细胞系质量控制。
本研究是更广泛的干细胞系项目Mito-Cell-UAB073的一部分,特别关注“干细胞系-质量控制”,旨在通过一种独特的人工智能(AI)驱动的模型,即生命细胞AI UAB,在质量控制(QC)领域进行创新。该模型利用深度学习算法和计算机视觉,使其能够仅根据通过标准光学显微镜捕获的静态图像对细胞和干细胞系进行准确的活力评估。目的:本研究的目的是开发和验证一个人工智能驱动的、基于图像的模型,该模型可以可靠地预测细胞系的生存能力。方法:我们的方法包括使用先进的计算机视觉和深度学习技术在细胞系的单个静态图像上训练Life Cell AI UAB模型。性能评估是在三个独立的盲测试集上进行的,这些盲测试集来自不同的生物技术实验室,允许在不同的环境中进行评估。结果:Life Cell AI UAB模型在识别活细胞系方面的灵敏度为82.1%,在识别非活细胞系方面的特异性为67.5%。每个盲测集的加权准确率均在63%以上,综合准确率为64.3%。值得注意的是,预测显示了正确和错误分类细胞之间的明显区别。该模型在二元分类任务中的准确率比传统QC方法提高了21.9% (p = 0.042),比传统的标准操作程序(SOP)程序提高了42.0% (p = 0.026)。结论:Life Cell AI UAB模型代表了生物银行QC的显著进步,为评估细胞系活力提供了一种精确、标准化和无创的方法。该模型具有简化实验室QC流程的潜力,最大限度地减少了对延时成像的需求,并促进了细胞和干细胞QC实践的统一性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biopreservation and Biobanking
Biopreservation and Biobanking Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
自引率
12.50%
发文量
114
期刊介绍: Biopreservation and Biobanking is the first journal to provide a unifying forum for the peer-reviewed communication of recent advances in the emerging and evolving field of biospecimen procurement, processing, preservation and banking, distribution, and use. The Journal publishes a range of original articles focusing on current challenges and problems in biopreservation, and advances in methods to address these issues related to the processing of macromolecules, cells, and tissues for research. In a new section dedicated to Emerging Markets and Technologies, the Journal highlights the emergence of new markets and technologies that are either adopting or disrupting the biobank framework as they imprint on society. The solutions presented here are anticipated to help drive innovation within the biobank community. Biopreservation and Biobanking also explores the ethical, legal, and societal considerations surrounding biobanking and biorepository operation. Ideas and practical solutions relevant to improved quality, efficiency, and sustainability of repositories, and relating to their management, operation and oversight are discussed as well.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信